Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Oslo - Delayed Quote NOK

Thor Medical ASA (TRMED.OL)

2.4000
-0.0550
(-2.24%)
At close: April 25 at 4:25:12 PM GMT+2
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
43,900
43,900
7,161
--
442,434
Operating Income
-43,900
-43,900
-7,161
--
-442,434
Net Non Operating Interest Income Expense
1,400
1,400
1,850
--
583
Pretax Income
-42,600
-42,600
-5,560
--
-440,138
Tax Provision
-400
-400
--
--
1,165
Net Income Common Stockholders
-42,200
-42,200
-26,561
-311,241
-441,303
Diluted NI Available to Com Stockholders
-42,200
-42,200
-26,561
-311,241
-441,303
Basic EPS
0.02
-0.18
-0.15
-2.64
-4.54
Diluted EPS
0.02
-0.18
-0.15
-2.64
-4.54
Basic Average Shares
239,468.0640
235,800
174,800
117,877.1520
97,081.2840
Diluted Average Shares
239,468.0640
235,800
174,800
117,877.1520
97,081.2840
Total Operating Income as Reported
-43,900
-43,900
-7,160
--
-442,434
Total Expenses
43,900
43,900
7,161
--
442,434
Net Income from Continuing & Discontinued Operation
-42,200
-42,200
-26,561
-311,241
-441,303
Normalized Income
-42,200
-42,200
-5,561
--
-441,303
Interest Income
1,500
1,500
2,019
--
1,141
Interest Expense
100
100
--
--
414
Net Interest Income
1,400
1,400
1,850
--
583
EBIT
-42,500
-42,500
-5,560
--
-439,724
EBITDA
-40,100
-40,100
-4,843
11,202
-428,353
Reconciled Depreciation
2,400
2,400
717
11,202
11,371
Net Income from Continuing Operation Net Minority Interest
-42,200
-42,200
-5,561
--
-441,303
Normalized EBITDA
-40,100
-40,100
-4,843
11,202
-428,353
Tax Rate for Calcs
0
0
--
--
0.0002
12/31/2021 - 3/23/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2QV0.F Chemomab Therapeutics Ltd.
1.0900
+2.83%
 
PBN.F Alterity Therapeutics Limited
0.0045
+12.50%
 
6XY.F HBM Holdings Limited
0.9000
+5.88%
 
FAB.L Fusion Antibodies plc
6.80
-9.09%
 
ELIC.ST Elicera Therapeutics AB (publ)
4.3500
+13.73%
 
FARN.L Faron Pharmaceuticals Oy
202.00
-0.25%
 
BIOVIC-B.ST Biovica International AB (publ)
0.6980
+9.06%
 
MEDCL.PA MedinCell S.A.
14.97
+0.13%
 
VVY.AS Vivoryon Therapeutics N.V.
1.7760
-1.88%
 
MDCLF MedinCell S.A.
6.98
0.00%